Have you heard of Addyi, the first and only drug approved to help women with low sexual desire?
If not, you are definitely not alone.
That’s the heart of a new battle over $800-a-month Addyi, often called “the female Viagra” because developers hoped for the same kind of blockbuster sales that erectile dysfunction drugs have seen.
